News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
306,546 Results
Type
Article (14124)
Company Profile (117)
Press Release (292305)
Section
Business (99258)
Career Advice (569)
Deals (20491)
Drug Delivery (64)
Drug Development (39915)
Employer Resources (49)
FDA (6968)
Job Trends (7161)
News (170971)
Policy (15513)
Tag
Academia (499)
Alliances (26368)
Alzheimer's disease (446)
Approvals (6983)
Artificial intelligence (67)
Bankruptcy (182)
Best Places to Work (5247)
Biotechnology (50)
Breast cancer (70)
Cancer (505)
Career advice (498)
Cell therapy (70)
Clinical research (33275)
Collaboration (215)
Compensation (90)
COVID-19 (796)
C-suite (58)
Data (532)
Diabetes (70)
Diagnostics (1816)
Drug pricing (61)
Earnings (35747)
Events (43490)
Executive appointments (243)
FDA (7247)
Funding (168)
Gene therapy (67)
GLP-1 (312)
Government (1390)
Healthcare (5041)
Infectious disease (820)
Inflammatory bowel disease (56)
Interviews (76)
IPO (9107)
Job creations (2149)
Job search strategy (447)
Layoffs (169)
Legal (3932)
Lung cancer (74)
Manufacturing (117)
Medical device (2913)
Medtech (2915)
Mergers & acquisitions (11551)
Metabolic disorders (202)
Neuroscience (573)
NextGen Class of 2024 (2214)
Non-profit (721)
Northern California (606)
Obesity (116)
Opinion (113)
Patents (77)
People (31444)
Pharmaceutical (67)
Phase I (8950)
Phase II (14302)
Phase III (12293)
Pipeline (231)
Policy (47)
Postmarket research (1426)
Preclinical (3591)
Radiopharmaceuticals (134)
Rare diseases (120)
Real estate (2938)
Regulatory (10825)
Research institute (650)
Resumes & cover letters (67)
Southern California (635)
Startups (1883)
United States (6307)
Vaccines (128)
Weight loss (82)
Date
Today (26)
Last 7 days (64)
Last 30 days (821)
Last 365 days (15206)
2025 (28)
2024 (15357)
2023 (17676)
2022 (23558)
2021 (24856)
2020 (23766)
2019 (18186)
2018 (14264)
2017 (16086)
2016 (14953)
2015 (18006)
2014 (14142)
2013 (11993)
2012 (12940)
2011 (13195)
2010 (12114)
Location
Africa (316)
Arizona (60)
Asia (21848)
Australia (2833)
California (1494)
Canada (751)
China (161)
Colorado (53)
Connecticut (68)
Europe (41469)
Florida (256)
Illinois (160)
Indiana (112)
Japan (58)
Kansas (57)
Maryland (219)
Massachusetts (1196)
Michigan (73)
Minnesota (83)
New Jersey (591)
New York (483)
North Carolina (407)
Northern California (606)
Pennsylvania (395)
South America (531)
Southern California (635)
Texas (223)
Virginia (48)
Washington State (106)
306,546 Results for "vyera pharmaceuticals llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase Agreement to Sell Rights to Daraprim and Vecamyl
Vyera Pharmaceuticals, LLC and Phoenixus AG announced that they have entered into an Asset Purchase Agreement related to Daraprim and Vecamyl.
August 1, 2023
·
4 min read
Pharm Country
Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals
Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera Pharmaceuticals.
December 7, 2023
·
1 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
October 2, 2024
·
6 min read
News
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
October 8, 2024
·
1 min read
Press Releases
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
October 29, 2024
·
6 min read
Deals
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.
November 27, 2023
·
4 min read
Deals
INTEGRATED ONCOLOGY NETWORK ANNOUNCES THE ACQUISITION OF UROLOGY PARTNERS, LLC
Integrated Oncology Network, LLC (“ION”), a portfolio company of Silver Oak Services Partners, LLC (“Silver Oak”), today announced the acquisition of Urology Partners, LLC.
May 2, 2024
·
3 min read
Alora Pharmaceuticals, LLC announces the availability of Once-Daily Relexxii® for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Alora Pharmaceuticals, LLC , the parent company of Vertical Pharmaceuticals, LLC, announced today the commercial availability of Relexxii ® (methylphenidate hydrochloride extended-release tablets).
December 19, 2023
·
3 min read
Press Releases
ITF Therapeutics LLC Announces Appointment of Erica L. Monaco, CPA, as Chief Operating Officer
December 4, 2024
·
7 min read
1 of 30,655
Next
